Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03695250
Title BMS-986205 and Nivolumab as First Line Therapy in Treating Patients With Liver Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Edward Kim
Indications

hepatocellular carcinoma

Therapies

BMS-986205 + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.